Notice of 2004 Annual Meeting of Shareholders
Morgan Stanley
2000 Westchester Avenue
Purchase, New York
April 20, 2004, 11:00 a.m., local time
 
March 4, 2004
 
Fellow shareholder:
 
We cordially invite you to attend Morgan Stanley’s 2004 annual meeting of shareholders to:
 
  elect three directors to the Board of Directors for a three-year term;
 
  ratify the appointment of Deloitte & Touche LLP as independent auditors;
 
  consider three shareholder proposals; and
 
  transact such other business as may properly come before the meeting.
 

Our Board of Directors recommends you vote “FOR” the election of directors and the ratification of auditors and “AGAINST” the shareholder proposals.
 
Enclosed are our proxy statement, a proxy card, our summary annual report and our 10-K annual report. If you currently receive paper versions of these documents, we are pleased to offer you an opportunity to receive future versions over the internet. By following the instructions on page 28, you will receive electronic access to these documents and will help reduce printing and postage costs.
 
We hope you will read the proxy statement and submit your proxy. We appreciate your cooperation.
 
Very truly yours,
 


 
Philip J. Purcell
Chairman and Chief Executive Officer
 

Table of Contents
Annual meeting information
Voting information
Item 1—Election of directors
New nominees
Board meetings and committees
Non-employee director meetings
Director compensation
Director attendance at annual meetings
Corporate governance
Beneficial ownership of Company common stock
Stock ownership of directors and executive officers
Principal shareholders
Executive compensation
Compensation Committee report on executive compensation
Summary compensation table
Option grants in last fiscal year
Aggregated option exercises in last fiscal year and fiscal year-end option values
Consulting Agreement
Pension plans
Stock performance graph
Item 2—Ratification of appointment of Morgan Stanley’s independent auditors
Audit Committee report
Shareholder proposals
Item 3—Shareholder proposal regarding staggered boards
Item 4—Shareholder proposal regarding golden parachutes
Item 5—Shareholder proposal regarding political contributions disclosure
Other Matters
Certain transactions
Other business
Shareholder communications with directors
Shareholder recommendations for director candidates
Shareholder proposals for the 2005 annual meeting
Cost of soliciting your proxy
Shareholders sharing an address
Electronic access to annual meeting materials
Annex: Definition of “Independent” Directors
 
Morgan Stanley
 
1585 Broadway
New York, New York 10036

March 4, 2004
 

Proxy Statement


 
We are sending you this proxy statement in connection with the solicitation of proxies by our Board of Directors for the 2004 annual meeting of shareholders. We are mailing this proxy statement and the accompanying form of proxy to shareholders on or about March 6, 2004. In this proxy statement, we refer to Morgan Stanley as the “Company,” “we” or “us.” When we refer to Morgan Stanley’s fiscal year, as in “fiscal 2003,” we mean the twelve-month period from December 1 through November 30.
 
Annual meeting information

Date and location of the annual meeting. We will hold the annual meeting on Tuesday, April 20, 2004 at 11:00 a.m., local time, at our offices at 2000 Westchester Avenue, Purchase, New York.
 
Admission to the annual meeting. Only record or beneficial owners of Morgan Stanley’s common stock may attend the annual meeting in person. When you arrive at the annual meeting, please present photo identification, such as a driver’s license. Beneficial owners must also provide evidence of stock holdings, such as a recent brokerage account or bank statement.
 
Electronic access to the annual meeting. You may listen to the meeting over the internet through our website at www.morganstanley.com. Please go to our website early to register and download any audio software.
 
Voting information

Record date. The record date for the annual meeting is February 20, 2004. You may vote all shares of Morgan Stanley’s common stock that you owned as of the close of business on that date. Each share of common stock entitles you to one vote on each matter to be voted on at the annual meeting. On the record date, 1,096,950,522 shares of common stock were outstanding. We need a majority of the shares of common stock outstanding on the record date present, in person or by proxy, to hold the annual meeting.
 
Confidential voting. Our Bylaws provide that your vote is confidential and will not be disclosed to any officer, director or employee, except in certain limited circumstances such as when you request or consent to disclosure. The Morgan Stanley 401(k) Plan (401(k) Plan) and the Employee Stock Ownership Plan (ESOP) also have confidential voting provisions.
 
Submitting voting instructions for shares held in your name. If you hold shares in your name as a record holder, you may vote your shares by proxy through the mail, telephone or internet as described on the proxy card. If you submit your proxy via the internet, you may incur costs such as telephone and internet access charges. Submitting your proxy will not limit your right to vote in person at the annual meeting. A properly completed and submitted proxy will be voted in accordance with your instructions, unless you subsequently revoke your instructions. If you submit a signed proxy card without indicating your vote, the person voting the proxy will vote your shares according to the Board’s recommendations.
 
Submitting voting instructions for shares held in employee plans. If you hold shares in, or have been awarded stock units under, certain employee plans, you will receive directions on how to submit your voting instructions by mail, telephone or internet. Shares held in the following employee plans also are subject to the following rules.
 
401(k) Plan, Financial Advisor Productivity Compensation Plan (FAPCP), Branch Manager Compensation Plan (BMCP), Employee Stock Purchase Plan (ESPP) and ESOP. The 401(k) Plan, FAPCP, BMCP, ESPP and ESOP trustee or custodian, as applicable, must receive your voting instructions for the common stock held on your behalf in these plans on or before April 18, 2004. If the trustee or custodian, as applicable, does not receive your voting instructions by that date, it will vote your shares (in the case of the ESOP, together with unallocated shares in the ESOP), in each applicable plan, in the same proportion as the voting instructions that it receives from other plan participants in the applicable plan. On February 20, 2004, there were 253,037 shares in the 401(k) Plan accounts, 1,418,940 shares in the FAPCP, 155,394 shares in the BMCP, 5,815,301 shares in the ESPP and 57,706,690 shares in the ESOP.

Other equity-based plans. State Street Bank and Trust Company acts as trustee for a trust (Trust) that holds shares of common stock underlying stock units awarded to employees under several of Morgan Stanley’s equity-based plans. Mellon Bank, N.A. (Mellon) is custodian of shares of restricted common stock awarded to employees under the 1995 Equity Incentive Compensation Plan (EICP). Employees allocated shares held in the Trust, or whose shares are held by Mellon, must submit their voting instructions for receipt by the trustee or Mellon, as applicable, on or before April 18, 2004. If the trustee does not receive your instructions by that date, it will vote your shares, together with shares held in the Trust that are unallocated or held on behalf of former Morgan Stanley employees and employees in certain foreign jurisdictions, in the same proportion as the voting instructions that it receives for shares held in the Trust in connection with such plans. If Mellon does not receive your instructions by that date, it will vote your shares in the same proportion as the voting instructions that the trustee receives for shares held in the Trust. On February 20, 2004, 60,392,795 shares were held in the Trust in connection with such plans and Mellon held 1,193,667 shares under the EICP.

Submitting voting instructions for shares held in street name. If you hold shares through a broker, follow the voting instructions you receive from your broker. If you want to vote in person, you must obtain a legal proxy from your broker and bring it to the meeting. If you do not submit voting instructions to your broker, your broker may still be permitted to vote your shares. New York Stock Exchange (NYSE) member brokers may vote your shares under the following circumstances.

Discretionary items. The election of directors and ratification of appointment of Morgan Stanley’s independent auditors are “discretionary” items. Member brokers that do not receive instructions from beneficial owners may vote on these proposals in the following manner: (1) Morgan Stanley’s wholly owned subsidiaries, Morgan Stanley & Co. Incorporated (MS&Co.) and Morgan Stanley DW Inc. (MSDWI), may vote your shares only in the same proportion as the votes cast by all record holders on the proposal; and (2) all other NYSE member brokers may vote your shares in their discretion.

Non-discretionary items. The shareholder proposals are “non-discretionary” items and may not be voted on by NYSE member brokers, including MS&Co. and MSDWI, absent specific voting instructions from beneficial owners.

If you do not submit voting instructions and your broker does not have discretion to vote your shares on a matter, your shares will not be counted in determining the outcome of the vote on that matter at the annual meeting.

Revoking your proxy. You can revoke your proxy at any time before your shares are voted by (1) delivering a written revocation notice prior to the annual meeting to Donald G. Kempf, Jr., Chief Legal Officer and Secretary, Morgan Stanley, 1585 Broadway, New York, New York 10036; (2) submitting a later proxy; or (3) voting in person at the annual meeting. Attending the annual meeting does not revoke your proxy.

Votes required to elect directors and to adopt other proposals. Directors are elected by a plurality of the votes cast. The ratification of Deloitte & Touche’s appointment and the approval of the shareholder proposals each requires the affirmative vote of a majority of the shares of common stock represented at the annual meeting and entitled to vote thereon.

Withholding your vote or voting to “abstain.” In the election of directors, you can withhold your vote for any nominee. Withheld votes will be excluded entirely from the vote and will have no effect on the outcome. On the other proposals, you can vote to “abstain.” If you vote to “abstain,” your shares will be counted as present at the annual meeting for purposes of that proposal and your vote will have the effect of a vote against the proposal.

 Item 1—Election of directors

Our Board currently has eleven (11) directors, divided into three classes. Members of each class serve for a three-year term. Shareholders elect one class of directors at each annual meeting. Each director holds office until his or her successor has been duly elected and qualified or the director’s earlier resignation, death or removal. Robert G. Scott, whose term expires in 2006, has informed the Company that he will retire immediately following the 2004 annual meeting. In addition, Robert P. Bauman, whose term expires at the annual meeting, has informed the Company that, consistent with the retirement provisions of the Board’s Corporate Governance Policies, he will not stand for reelection. Our Board has nominated Sir Howard Davies to replace Mr. Bauman. Therefore, upon Messrs. Scott’s and Bauman’s retirement, the size of the Board will be reduced to ten (10) members and the class of directors whose term expires in 2006 will be reduced from four (4) to three (3).

The Board proposes, based on the recommendation of its Nominating and Governance Committee, the election of John W. Madigan, Dr. Klaus Zumwinkel and Sir Howard Davies as directors for a term ending at the 2007 annual meeting. Mr. Madigan and Dr. Zumwinkel are current directors of Morgan Stanley. Each nominee has indicated that he will serve if elected. We do not anticipate that any nominee will be unable or unwilling to stand for election, but if that happens, your proxy will be voted for another person nominated by the Board.

Nominees for election for a three-year term ending in 2007
 
John W. Madigan (66). Chairman (January 1996 to December 2003), Chief Executive Officer (May 1995 to December 2002) and President (May 1994 to July 2001) of Tribune Company, a media company.

Director since: July 2000

Other directorships: AT&T Wireless Services, Inc.
 
Dr. Klaus Zumwinkel (60). Chairman of the Board, Deutsche Post AG, a global corporation comprised of four business divisions, including mail, express (including DHL Worldwide), logistics and financial services (since 1995).

Director since: February 2004

Other directorships: Deutsche Lufthansa AG (Supervisory Board), Deutsche Telekom AG (Chairman, Supervisory Board), Karstadt Quelle AG (Supervisory Board) and C.V. International Post Corp., U.A. (Board of Directors).
 
Sir Howard Davies (53). The Director, London School of Economics and Political Science (since September 2003). Chairman and Chief Executive, the UK Financial Services Authority (August 1997 to September 2003). Deputy Governor, the Bank of England (September 1995 to August 1997).
 
 
Our Board of Directors recommends a vote “FOR” the election of all three nominees. Proxies solicited by our Board of Directors will be voted “FOR” these nominees unless otherwise instructed.

Directors continuing in office—term expiring in 2005
 
John E. Jacob (69). Executive Vice President-Global Communications of Anheuser-Busch Companies, Inc., a global corporation that includes a brewing organization, a manufacturer of aluminum beverage containers and park operations (since 1994). President and Chief Executive Officer of National Urban League, Inc. (1982 to 1994).

Director since: September 2001

Other directorships: Anheuser-Busch Companies, Inc. and Coca-Cola Enterprises Inc.
 
Charles F. Knight (68). Chairman (since 1974), Chief Executive Officer (1973 to October 2000) of Emerson Electric Co., a manufacturer of electronic and electrical products.

Director since: January 1999

Other directorships:  Anheuser-Busch Companies, Inc., Emerson Electric Co., International Business Machines Corporation, SBC Communications Inc. and BP p.l.c.
 
Miles L. Marsh (56). Chairman and Chief Executive Officer of Fort James Corporation, a manufacturer and marketer of consumer paper products (August 1997 to November 2000). Chairman (January 1996 to August 1997) and President and Chief Executive Officer (October 1995 to August 1997) of James River Corporation of Virginia.

Director since: May 1997; Director of Dean Witter, Discover & Co. (December 1996 to May 1997)

Other directorships: GATX Corporation and Whirlpool Corporation
 
Dr. Laura D’Andrea Tyson (56). Dean of the London Business School (since January 2002). Dean (July 1998 to December 2001) and Class of 1939 Chair in Economics and Business Administration (January 1997 to July 1998) at the Walter A. Haas School of Business at the University of California, Berkeley. Chair of the President’s National Economic Council (February 1995 to December 1996).

Director since: May 1997; Director of Morgan Stanley Group Inc. (April 1997 to May 1997)

Other directorships: Eastman Kodak Company, SBC Communications Inc. and Human Genome Sciences, Inc.
 
Directors continuing in office—term expiring in 2006
 
Philip J. Purcell (60). Chairman of the Board and Chief Executive Officer (since May 1997). Chairman and Chief Executive Officer of Dean Witter, Discover & Co. (1986 to May 1997). Director or trustee of approximately 100 registered investment companies for which Morgan Stanley Investment Advisors Inc., a wholly owned subsidiary of Morgan Stanley, serves as investment manager or investment adviser.

Director since: May 1997; Chairman of the Board of Dean Witter, Discover & Co. (1986 to May 1997)

Other directorships: AMR Corporation
 
C. Robert Kidder (59). President (November 2001 to March 2003) of Borden Capital, Inc., a company which provided financial and strategic advice to the Borden family of companies. Chairman of the Board (since January 1995) and Chief Executive Officer (January 1995 to March 2002) of Borden Chemical, Inc. (formerly Borden, Inc.), a forest products and industrial chemicals company.

Director since: May 1997; Director of Dean Witter, Discover & Co. (July 1993 to May 1997)

Other directorships: Electronic Data Systems Corporation and Borden Chemical, Inc.
 
Michael A. Miles (64). Special Limited Partner (since January 1995) in Forstmann Little & Co., a private investment firm with interests in telecommunications, broadcasting, healthcare and other industries.

Director since:
May 1997; Director of Dean Witter, Discover & Co. (February 1993 to May 1994; January 1995 to May 1997)

Other directorships: Sears, Roebuck and Co., The Allstate Corporation, Time Warner Inc., Dell Computer Corporation, AMR Corporation, Exult, Inc., Community Health Systems, Inc. and Citadel Broadcasting Corp.
 
New nominees. At the direction of the Nominating and Governance Committee, which consists solely of independent directors, the Company retained a third party search firm, Heidrick and Struggles, to identify potential board candidates with international experience. The CEO provided the names of several potential director candidates, including Dr. Klaus Zumwinkel and Sir Howard Davies, to Heidrick and Struggles to consider for inclusion in a list of potential director candidates that it prepared for the Committee. The Nominating and Governance Committee Chair and the CEO asked several Committee members to meet with both nominees so that the Committee members could assess the nominees as director candidates. All Committee members who met the nominees recommended them as potential directors to the Committee. The Committee, in turn, unanimously recommended to the full Board that Dr. Zumwinkel be elected as a director and that Sir Howard Davies be nominated for election. The Board followed the Committee’s recommendation.
 
Board meetings and committees. Our Board met 10 times during fiscal 2003. Each director attended at least 78% of the total number of meetings of the Board and committees on which the director served that were held while the director was a member. As a group, the directors attended approximately 94% of the total number of meetings of the Board and committees on which the directors served while the directors were members. The Board’s standing committees include the following:
 
Committee Members Primary Responsibilities # of Meetings
Audit C. Robert Kidder (Chair)
John E. Jacob
John W. Madigan
Laura D’Andrea Tyson
  Monitors the integrity of the Company’s consolidated financial statements, the Company’s compliance with legal and regulatory requirements and the Company’s system of internal controls.

  Selects, evaluates and, when appropriate, replaces the independent auditor, and pre-approves audit and permitted non-audit services.

  Monitors the qualifications, independence and performance of the Company’s internal and independent auditors.
8
Compensation Charles F. Knight (Chair)
Robert P. Bauman
C. Robert Kidder
Miles L. Marsh
  Determines the compensation of our executive officers and such other officers as deemed appropriate.

  Annually reviews and approves the corporate goals and objectives relevant to the compensation of the CEO and evaluates his performance in light of these goals and objectives.

  Administers our incentive and equity-based compensation plans.
6
Nominating and Governance Michael A. Miles (Chair)
Robert P. Bauman
John E. Jacob
John W. Madigan
Miles L. Marsh
Laura D’Andrea Tyson
  Identifies and recommends candidates for election to the Board.

  Establishes procedures for its oversight of the evaluation of the Board and management.

  Recommends director compensation and benefits.

  Reviews annually our corporate governance policies.
3

Our Board has adopted written charters for the Audit, Compensation and Nominating and Governance Committees setting forth the roles and responsibilities of each committee. These charters are available at www.morganstanley.com. The Board has determined that each non-management director and director nominee is independent in accordance with the standards of independence established under our Corporate Governance Policies (attached as an Annex). All members of the Audit, Compensation and the Nominating and Governance Committees satisfy the standards of independence applicable to members of such committees established under applicable law and NYSE listing requirements. In addition, the Board has determined that each of Mr. Kidder and Mr. Madigan is an “audit committee financial expert” within the meaning of the current rules of the Securities and Exchange Commission (SEC).
 
Non-employee director meetings. The non-employee directors met two (2) times in fiscal 2003 without any Company representative present. Pursuant to the Company’s Corporate Governance Policies, the chair of the Audit, Compensation or Nominating and Governance Committee leads the non-employee Board sessions and is chosen by the non-employee directors based on who is the most knowledgeable and appropriate leader given the subject of the meeting. The session leader can retain independent consultants and schedule meetings.
 
Director compensation. Employee directors receive no compensation for Board service.
 
Fees. The Corporate Governance Policies provide that the Company should not enter into paid consulting agreements with non-employee directors. Non-employee directors receive the following retainers and fees for their Board service:
 
 
  Board Member $ 35,000   annually
  Committee Chair $ 7,500   annually
  Committee Member $ 5,000   annually
  Attendance at Board or Committee Meeting
 
$ 1,000   per meeting
Directors’ Equity Capital Accumulation Plan (DECAP). Under DECAP, non-employee directors receive 6,000 stock options and 2,000 shares of common stock upon becoming a director and annually thereafter while a director. Stock options have an exercise price equal to the fair market value of a share of common stock on the award date. DECAP also provides that the non-employee directors may elect to (1) receive all or a portion of their annual committee retainers, on a current or deferred basis, in cash or shares of common stock; (2) receive all or a portion of their meeting fees, on a current or deferred basis, in cash or in shares of common stock (with respect to elections to receive common stock on a current basis, meeting fees are credited to a cash deferral account until the date of the next annual meeting); (3) defer receipt of common stock grants; and (4) receive the annual $35,000 Board retainer either in shares of common stock, on a current or deferred basis, or in stock options (the number of stock options is obtained by dividing $35,000 by the fair market value of a share of common stock on the award date and multiplying the result by three; each stock option has an exercise price equal to the fair market value of a share of common stock on the award date). Directors receive dividends on any deferred common stock in the form of additional deferred common stock.
 
Other benefits. Morgan Stanley matches certain charitable gifts by non-employee directors up to $2,000 per year. During fiscal 2003, we matched $2,000 in charitable gifts on behalf of each of John E. Jacob and Charles F. Knight. Miles L. Marsh received Company-provided transportation valued at $1,099. Non-employee directors do not receive Company retirement benefits.

Director attendance at annual meetings. In 2003, our Board revised the Company’s Corporate Governance Policies to state that directors are expected to attend annual meetings of shareholders. Two directors attended the 2003 meeting, which was held before our Board revised the policies.
 
Corporate governance
 
Our Board has maintained corporate governance policies for many years and has updated them from time to time. Our Board has had in place several of the NYSE’s new corporate governance requirements for many years. Corporate governance highlights are listed below.
 
  Our Board has a substantial majority (82%) of non-employee directors. Upon Mr. Scott’s retirement, our Board will be composed of 90% non-employee directors. Since our Board adopted its Corporate Governance Policies, all non-employee directors have been independent in accordance with those policies.
 
  Our director independence definition is more stringent than required by the NYSE.
 
  Since 1994, only non-employee directors have comprised our Audit, Compensation and Nominating and Governance committees.
 
  All of our Audit Committee members meet NYSE standards for independence, financial literacy and financial management expertise. Two members of the Audit Committee are “audit committee financial experts” under SEC rules.
 
  Our Audit Committee hires, determines the compensation of, and decides the scope of services performed by our independent auditors. It also has authority to retain independent outside advisors.
 
  Our Corporate Governance Policies provide that the Company should not enter into paid consulting agreements with non-employee directors.
 
  Our Compensation Committee retained an independent consultant, Towers Perrin, to assist it.
 
  Our Compensation Committee evaluates the CEO and discusses the evaluation with the Board in executive session.
 
  Our Nominating and Governance Committee retained an independent consultant, Towers Perrin, to advise it on director compensation. At the direction of the Nominating and Governance Committee, the Company retained an independent consultant, Heidrick and Struggles, to advise on potential director candidates.
 
  Our Code of Ethics and Business Conduct applies to our directors, officers and employees and sets forth basic principles to guide their day-to-day activities.
 
  Our Corporate Governance Policies oppose the re-pricing of our outstanding stock options.
 
  Our Bylaws provide for confidential voting.
 
  Our Management Committee has adopted an Equity Ownership Commitment that its members retain 75% of net equity held and equity subsequently awarded to them.
 
The Corporate Governance Policies (including our independence definition), Code of Ethics and Business Conduct, Board committee charters and Management Committee Equity Ownership Commitment are available at www.morganstanley.com.
 
Beneficial ownership of Company common stock
 
Stock ownership of directors and executive officers. We encourage stock ownership by our directors, officers and employees to align their interests with your interests as shareholders. The following table sets forth the beneficial ownership of common stock, as of January 30, 2004, by each of our directors and executive officers named in the summary compensation table (Named Executive Officers), as well as by all our directors, director nominees and executive officers as a group.
 
Common Stock Beneficially Owned as of January 30, 2004

Name Shares(1) Underlying
Stock Units(2)
Subject to
Stock Options
Exercisable within 60
days of 1/30/04(3)
Total(4)
NAMED EXECUTIVE OFFICERS
Philip J. Purcell 2,790,157 464,726 2,618,744 5,873,627
Robert G. Scott 1,979,111 451,791 1,303,832 3,734,734
Stephan F. Newhouse 386,639 676,714 942,454 2,005,807
Vikram S. Pandit 352,071 1,242,530 1,471,289 3,065,890
Zoe Cruz 103,068 733,686 780,492 1,617,246

DIRECTORS AND DIRECTOR NOMINEES
Robert P. Bauman 6,152 11,723 68,108 85,983
Sir Howard Davies 0 0 0 0
John E. Jacob 1,000 6,748 24,000 31,748
C. Robert Kidder 19,500 16,143 84,108 119,751
Charles F. Knight 2,012 12,729 48,000 62,741
John W. Madigan 0 6,610 39,177 45,787
Miles L. Marsh 13,200 8,002 64,000 85,202
Michael A. Miles 42,788 15,901 76,108 134,797
Dr. Laura D’Andrea Tyson 7,498 1,222 53,796 62,517
Dr. Klaus Zumwinkel 0 0 0 0
All directors, director nominees and
executive officers as a group (24 persons) 6,651,336 7,074,749 13,876,816 27,602,901

(1) Each director and executive officer has sole voting and investment power with respect to these shares, except as described in this footnote: 45,362 shares owned by Mr. Purcell’s spouse and 5,696 shares held for Mr. Purcell’s child in a custodial account for which Mr. Purcell is custodian, with respect to all of which he disclaims beneficial ownership; 150,000 shares contributed by Mr. Scott to an exchange fund, with respect to which the fund’s investment manager has sole voting and investment power but which Mr. Scott may redeem within 60 days if the fund then holds the shares; and 241,047 shares, shown in the table as held by the directors, director nominees and executive officers as a group (20,000 of which beneficial ownership has been disclaimed), with respect to which certain executive officers (other than Named Executive Officers) have shared voting and investment power with family members.

(2) Shares of common stock held in the Trust corresponding to stock units. Directors and executive officers may direct the voting of the shares corresponding to their stock units. Voting by executive officers is subject to the voting provisions of the Trust described on page 2.

(3) Includes options granted to executive officers in respect of fiscal 2003, 2002 and 1999 compensation.

(4) Each executive officer and director beneficially owned less than 1% of the shares of common stock outstanding. All directors and executive officers as a group beneficially owned approximately 2.5% of the common stock outstanding.

Principal shareholders. The following table contains information regarding the only persons we know of that beneficially own more than 5% of our common stock.
 
    Shares of Common Stock
Beneficially Owned
  Name and Address Number Percent
  State Street Bank and Trust Company(1)
225 Franklin Street, Boston, MA 02110
94,267,589 8.7%
 
FMR Corp.(2)
82 Devonshire Street, Boston, MA 02109
83,984,148 7.7%
 
Barclays Global Investors, N.A.,
and other reporting entities(3)
45 Fremont Street, San Francisco, CA 94105
55,075,614 5.1%

(1) Based on a Schedule 13G Information Statement filed February 4, 2004 by State Street, acting in various fiduciary capacities. The Schedule 13G discloses that State Street had sole voting power as to 27,155,932 shares, shared voting power as to 64,664,771 shares, sole dispositive power as to 28,475,012 shares and shared dispositive power as to 65,792,577 shares; that shares held by State Street on behalf of the Trust and a Company-sponsored equity-based compensation program amounted to 6.1% of the common stock; and that State Street disclaimed beneficial ownership of all shares reported therein.

(2) Based on a Schedule 13G Information Statement filed February 17, 2004 by FMR, Edward C. Johnson 3d, Abigail P. Johnson and Fidelity Management & Research Company (Fidelity), a wholly owned subsidiary of FMR. Certain of the shares listed above are beneficially owned by FMR subsidiaries and related entities. The Schedule 13G discloses that FMR had sole voting power as to 5,704,552 shares and that Mr. and Ms. Johnson did not have sole voting power as to any shares. The Schedule 13G also discloses that FMR and Mr. and Ms. Johnson had sole dispositive power as to all shares and no shared voting or dispositive power. The Schedule 13G states that Mr. and Ms. Johnson and various family members, through their ownership of FMR voting common stock and the execution of a shareholders’ voting agreement, may be deemed to form a controlling group with respect to FMR. The Schedule 13G indicates that 77,812,326 shares are beneficially owned by Fidelity as a result of acting as an investment adviser to several investment companies (ICs). Mr. Johnson, FMR, through its control of Fidelity, and the ICs each had sole dispositive power as to all such shares. Neither Mr. Johnson nor FMR had sole voting power as to such shares, as such power resides with the ICs’ Boards of Trustees and is carried out by Fidelity under written guidelines established by such Boards. The Schedule 13G also indicates that 4,126,755 shares are beneficially owned by Fidelity Management Trust Company (Fidelity Trust), a wholly owned subsidiary of FMR, as a result of its serving as investment manager of certain institutional accounts. Mr. Johnson and FMR, through its control of Fidelity Trust, each had sole dispositive power as to all such shares and sole voting power as to 3,651,355 shares. The Schedule 13G indicates that 2,036,110 shares are beneficially owned by Fidelity International Limited (FIL), an entity independent of FMR. Mr. Johnson is Chairman of FIL, and approximately 40% of the voting power of FIL is held by a partnership controlled by him and family members. FIL had sole voting and dispositive power as to all such shares. FMR and FIL are of the view that they are not required to attribute to each other shares beneficially owned by the other corporation.

(3) Based on a Schedule 13G Information Statement filed February 17, 2004 by Barclays Global Investors, N.A., Barclays Global Fund Advisors, Barclays Global Investors, Ltd, Barclays Global Investors Japan Trust and Banking Company Limited, Barclays Life Assurance Company Limited, Barclays Bank PLC, Barclays Capital Securities Limited, Barclays Capital Inc., Barclays Private Bank & Trust (Isle of Man) Limited, Barclays Private Bank and Trust (Jersey) Limited, Barclays Bank Trust Company Limited, Barclays Bank (Suisse) SA and Barclays Private Bank Limited. In the Schedule 13G, the reporting entities do not affirm the existence of a group. The Schedule 13G discloses that the reporting entities, taken as a whole, had sole voting and sole dispositive power as to 48,217,483 shares and 48,271,543 shares, respectively, and did not have shared power as to any shares.

Executive compensation

Compensation Committee report on executive compensation.

Compensation governance. The Compensation Committee is responsible to Morgan Stanley’s Board of Directors and to shareholders for approving compensation awarded to all members of the Company’s Management Committee, including the Named Executive Officers. The Committee authorizes all awards under Morgan Stanley’s equity-based compensation plans and operates under a written charter adopted by the Board.

Compensation policies. Our fundamental policy is to link closely our Management Committee’s compensation with the achievement of annual and long-term performance goals. We award compensation based upon Company, business unit and individual performance in a manner that motivates our Management Committee members to achieve strategic business objectives and continue to perform at the highest levels in the future. We provide total compensation that we believe is comparable to that of Morgan Stanley’s competitors, thereby enabling Morgan Stanley to attract and retain employees critical to its long-term success and the creation of shareholder value. We also include a significant equity component in total compensation because we believe that equity-based compensation aligns the long-term interests of employees with those of shareholders.

We consider several factors in awarding compensation. We assess Morgan Stanley’s results and compare them to estimates of competitors’ results. We also receive input and estimates from external sources of what our competitors will pay their key employees. External sources also provide input regarding the competitive marketplace for the talents and skills of Morgan Stanley’s employees. We utilize both quantitative and qualitative factors when determining total compensation for Management Committee members and when awarding equity-based compensation to employees. Quantitative factors include, among others, absolute levels of, and year-to-year changes in, return on equity (ROE), consolidated net revenues, consolidated net income, profit before taxes, earnings per share, book value per share, market share and several key business drivers. Qualitative factors include achievement of pre-established performance goals, differentiating our brand, customer satisfaction, retaining key employees and subjective assessments of individual performances. We utilize ROE as a key measure of corporate performance, both on an absolute basis and compared to estimates of our competitors’ performance. We also review the ratios of compensation to net revenues and compensation to pre-compensation profit before taxes. We review survey data regarding competitors for purposes of monitoring Management Committee compensation levels in relation to similar jobs in the marketplace. We engaged Towers Perrin to provide independent insights on executive compensation matters, both generally and within our industry. We considered all these factors, but determined total compensation based upon a more subjective process, focusing primarily on Company and business unit financial performance, on an absolute and comparative basis, individual performance and expected market compensation.

Our policy is to maximize the tax deductibility of compensation payments to Management Committee members under Section 162(m) of the Internal Revenue Code and the regulations thereunder (Section 162(m)). Our shareholders have approved our incentive plans designed and administered to qualify compensation awarded thereunder as “performance-based.” We may, however, authorize payments to Management Committee members that may not be fully deductible if we believe such payments are in our shareholders’ interests.

Compensation program. Our Management Committee members receive annual compensation (excluding employee benefits) composed of base salary and incentive compensation consisting of a cash bonus and equity-based awards (restricted stock units and stock options). Base salary and incentive compensation constitute a Management Committee member’s “Total Reward.” In general, the greater the Total Reward, the greater the percentage of the total that is awarded in the form of long-term, equity-based compensation.

1. Base salaries. Management Committee members receive a relatively small portion of their overall compensation as base salary. We consider individual experience, responsibilities and tenure when determining base salaries. Base salaries are generally in the range of median base salaries paid by certain key competitors included in the group of Financial Services Companies identified below to employees having duties and responsibilities comparable to those of our Management Committee members.
 
2. Incentive compensation. Our Management Committee members’ Total Reward is heavily weighted towards performance-based long-term incentive compensation. Their annual incentive compensation varies by Company, business unit and individual performance. We believe this links their compensation with Company, business unit and individual performance, and is consistent with our compensation policies discussed above. Generally, a portion of the annual incentive compensation is paid in cash, and a significant portion is paid in equity. During employment, equity awards vest 50% two years after grant and 50% three years after grant, and option and unit shares are not transferable for approximately five years after grant. The value of equity awards cannot be realized immediately and depends upon the future market value of Morgan Stanley’s stock. We believe that equity-based compensation, the value of which depends upon the Company’s future financial performance and stock price, provides a continuing incentive to Management Committee members to continue in employment and foster Morgan Stanley’s success long after we award the compensation. We believe it also aligns their interests with those of shareholders.
 
Compensation for fiscal 2003. We analyzed several different factors when awarding incentive compensation for fiscal 2003. We:
 
  considered Morgan Stanley’s ROE on an absolute and comparative basis;

  reviewed Morgan Stanley’s achievements and financial performance for fiscal 2003 and individual and business unit performance, both on an absolute basis and against pre-established performance goals;

  compared Morgan Stanley’s and its business units’ financial performance in fiscal 2003 to the estimated financial performance of most of the Financial Services Companies identified below, including key competitors in that group, and certain other competitors;

  considered market share progress in each of the Company’s business units;

  considered the estimated compensation levels of executives of the Financial Services Companies and other competitors; and

  considered positive differentiation of reputation and brand, including positive client development, on an absolute and comparative basis.
 
These factors were not, however, the sole items we considered, and we did not target Total Rewards to fall at any particular point within a range established by a comparison of the financial performance of, or compensation levels of, the Financial Services Companies or the other competitors operating in the same or similar businesses as the Company. For purposes of this report, the term “Financial Services Companies” means the following companies (or subdivisions thereof): Alliance Capital Management; American Express Company; Bank One Corporation; The Bear Stearns Companies Inc.; BlackRock, Inc.; Capital One Financial Corporation; Citigroup Inc.; Credit Suisse Group; Deutsche Bank AG; The Goldman Sachs Group, Inc.; J.P. Morgan Chase & Co.; Lehman Brothers Holdings Inc.; MBNA Corporation; Merrill Lynch & Co., Inc.; MFS Investment Management; Putnam Investments; T. Rowe Price Group, Inc.; UBS AG; and Wachovia Corporation.
 
We believe Morgan Stanley performed well in 2003, in securities markets that generally improved during the year. Fixed income trading, capital markets, mergers and acquisitions and IIG all experienced increasing business activities, particularly during the second half of the year. The Company increased market share in announced M&A and global equity underwriting, maintained a leading market share role in equity secondary trading and had stable market shares in fixed income and IIG. It also experienced market share declines in Investment Management and Credit Services.

Net income increased 27% from $2.99 billion in fiscal 2002 to $3.79 billion in fiscal 2003 driven by improved results in Institutional Securities and IIG that were partially offset by weaker results in Investment Management and Credit Services. The Company strengthened its balance sheet, improved its capital and liquidity positions, had the lowest adjusted leverage of its peers and maintained strong credit ratings, including ratings from Fitch, Moody’s and Standard & Poor’s of “AA–”, “Aa3” and “A+”, respectively. The Company ROE was 16.5%, a strong performance in the 2003 business environment, and up 17% from 14.1% in 2002. Consolidated net revenues increased 9% from $19.12 billion in fiscal 2002 to $20.86 billion in fiscal 2003.

We certified in accordance with Section 162(m) that Morgan Stanley’s financial results for fiscal 2003 satisfied the performance criteria set in accordance with Section 162(m) for fiscal 2003. After an analysis of the considerations set forth above, we awarded above-base incentive compensation to the Management Committee members for fiscal 2003 that was equal to or below the maximum amount yielded by the application of the compensation formula contained in the performance criteria. We awarded incentive compensation to the Management Committee members, partly in cash and partly in the form of long-term equity components (restricted stock units and options). We awarded an average of approximately 40% of each Management Committee member’s Total Reward in long-term equity. We ascribed value to restricted stock units based on a 25% discount from the fair market value of the common stock to compensate for the vesting characteristics and the significant restrictions on disposition of these units. Accordingly, the value we ascribed to such units differs from the amounts reported in the summary compensation table under the column headed “Restricted Stock Awards” because the amounts contained in the table are based on the fair market value of the common stock on the grant date without any discount. We valued stock option awards based upon a ratio of three options per share of Morgan Stanley’s common stock (2.25:1 with a 25% discount). The ratio is based upon Morgan Stanley’s historical practices and is competitive with Morgan Stanley’s key competitors’ compensation practices.

CEO compensation for fiscal 2003. The CEO’s salary is based on the criteria described in this report. Based upon competitive data, we did not increase the CEO’s salary for fiscal 2003.

We determined incentive compensation for Mr. Purcell in accordance with the policies described above relating to all Management Committee members based on substantially the same factors and Section 162(m) performance criteria as for the other Management Committee members. In addition, we considered Mr. Purcell’s work with several important institutional clients. Based on his individual and Morgan Stanley’s overall performance, Mr. Purcell’s Total Reward was $14,000,000, consisting of the following components:
 
Base Salary   Cash Bonus   73,493 Restricted Units   165,360 Stock Options   Total  
$775,000   $7,112,500   $3,056,250   $3,056,250   $14,000,000  
 
The equity-based awards contain the terms and conditions discussed in the tables on pages 14 through 15. Approximately 44% of Mr. Purcell’s incentive compensation was equity-based and its value is tied to the performance of Morgan Stanley’s common stock. Mr. Purcell’s compensation reflects the Company’s financial performance and his individual leadership displayed throughout the year.
 
Conclusion. Attracting and retaining talented and motivated management and employees is essential to create long-term shareholder value. Offering a competitive, performance-based compensation program with a large equity component helps to achieve this objective by aligning the interests of Management Committee members and other key employees with those of shareholders. We believe that Morgan Stanley’s fiscal 2003 compensation program met these objectives.

Respectfully submitted,

Charles F. Knight, Chair
Robert P. Bauman
C. Robert Kidder
Miles L. Marsh

Summary compensation table. The following table contains information with respect to the CEO and the four other most highly compensated executive officers.
 
    ANNUAL COMPENSATION   LONG-TERM
COMPENSATION
AWARDS
   
Name and Principal Position Fiscal
Year
Salary ($)(1) Bonus ($)(1) Other Annual
Compensation ($)
Restricted
Stock
Awards ($)(2)
Securities
Underlying
Options (#)
  All Other
Compensation ($)(3)
 Philip J. Purcell 2003 775,000   7,112,500     156,341 (4)   4,062,693   165,360 (5)    17,480
 Chairman of the Board 2002 775,000   5,612,500         3,063,570   162,572 (5)   14,590
 and CEO 2001 775,000   7,612,500         4,410,193   173,934 (5)   19,690

 Robert G. Scott*
2003 550,000   14,839,000 (6)   132,853 (4)         17,480
 President and COO 2002 550,000   5,475,000         2,972,240   157,726 (5)   14,590
                        284,189 (7)    
                        441,915      
  2001 474,658   7,262,671         4,176,858   164,732 (5)   19,690

 Stephan F. Newhouse*
2003 425,000   6,787,500     909,149 (8)   3,846,658   156,567 (5)   17,480
 Co-President and COO of 2002 425,000   5,287,500     247,575 (8)   2,847,711   151,117 (5)   14,590
 Institutional Securities Group 2001 425,000   7,037,500     245,470 (8)   4,026,703   158,809 (5)   19,690

 Vikram S. Pandit*
2003 425,000   6,787,500         3,846,658   156,567 (5)   17,480
 Co-President and COO of 2002 425,000   5,287,500         2,847,711   151,117 (5)   14,590
 Institutional Securities Group 2001 425,000   7,037,500         4,026,703   158,809 (5)   19,690

 Zoe Cruz
2003 300,000   7,850,000         4,552,860   185,311 (5)   17,480
 Head of Worldwide 2002 300,000   4,600,000         2,391,063   126,886 (5)   14,590
 Fixed Income, FX and                              
 Commodities 2001 300,000   5,350,000         2,901,220   114,421 (5)   19,690
 
* Mr. Scott retired as President and Chief Operating Officer November 30, 2003. On December 1, 2003, Mr. Newhouse became President of Morgan Stanley, and Mr. Pandit became President and COO of Institutional Securities.

(1) Includes amounts contributed to various Morgan Stanley deferred compensation plans.

(2) The market value of the common stock underlying restricted stock units (RSUs) using the closing price per share of common stock on the applicable grant date, as reported on the New York Stock Exchange Composite Transaction Tape, and without recognizing any diminution in value attributable to the restrictions on RSUs. Fiscal 2003 RSUs were granted on November 28, 2003 (the closing price on that date was $55.28) and vest 50% on January 2, 2006 and the final 50% on January 2, 2007. Fiscal 2002 RSUs were granted on December 5, 2002 (the closing price on that date was $42.40) and vest on January 2, 2005. Fiscal 2001 RSUs were granted on December 6, 2001 (the closing price on that date was $57.05) and vested on January 2, 2004. All unvested RSUs are subject to earlier vesting upon termination of employment without cause or upon a change of control of Morgan Stanley and receive dividend equivalents at the same rate that dividends are paid on shares of common stock. These RSUs are neither transferable nor generally distributed in the form of shares of common stock for five years after the grant date and are subject to cancellation in certain circumstances. The following lists the number of RSUs awarded in each applicable year and the total number and value of RSUs held as of fiscal 2003 year end (including the fiscal 2003 grant). The value ascribed to RSUs in this table differs from the value ascribed to them by the Compensation Committee. See the Compensation Committee report on executive compensation, beginning on page 11.